Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

06/04/2018 Stradivarius Counts On Omnichannel and Aitana Ocaña 21/03/2018 Sun and salt: SENER’s know-how 15/03/2018 Major Upgrade of an ALBA Synchrotron Beamline 01/03/2018 ALBA Synchrotron is as good at humanities as at sciences! 23/02/2018 Catalonia, 2018/19 Top Southern European Region for FDI Strategy 15/02/2018 ICMAB traps sunlight with superabsorbent nanomaterials
11 12 13 14 15 16 17 18 19 20 21